Ledger.Open graph →
SEC Form D · filed September 26, 2019

Edgewise Therapeutics, Inc

Offering
$50.1M
Sold
$25.1M
Exemption
Rule 506(b)
Industry
Other Technology
Location
Boulder, CO
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

David Wolenski · Irvine, CADirectorJoseph Gissy · Manchester, MODirectorMichael Packamn · Jericho, NYDirectorKeystone 1031 LLC · Jericho, NYDirectorGene Chen · Irvine, CAExec · DirectorGrant Mccullagh · Asheville, NCExec · DirectorTimothy Mcloughlin · Asheville, NCDirectorLee Lance · Asheville, NCDirectorWalton Ward · San Marcos, TXDirectorErin Link · San Marcos, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗